DRW Securities’s Immune Design Corp. IMDZ Stock Holding History

DRW Securities’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$13K	–	122
2018 Q4	$13K	Sell	10,000 -70,000	-88%	-$122K	﹤0.01%	67
2018 Q3	$276K	Buy	80,000 +21,100	+36%	+$79.2K	0.02%	34
2018 Q2	$268K	Buy	58,900 +21,900	+59%	+$87.2K	0.02%	55
2018 Q1	$122K	Buy	37,000 +20,000	+118%	+$70.8K	0.01%	142
2017 Q4	$66K	Buy	+17,000	New	+$92.6K	0.01%	446

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

DRW Securities's IMDZ Position: Q1 2019 in Review

DRW Securities sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 10,000 shares — an estimated $13K sold.

DRW Securities first reported a position in IMDZ in Q4 2017 and held it in 5 quarters. The position peaked at $276K in Q3 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

DRW Securities reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
DRW Securities sold 10,000 Immune Design Corp. shares in Q1 2019, an estimated $13K.
DRW Securities first reported a position in Immune Design Corp. in Q4 2017 and held it in 5 quarters.
DRW Securities's Immune Design Corp. position peaked at $276K in Q3 2018.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on DRW Securities's 13F filing for Q1 2019, filed 15 May 2019.